Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors:
SEC Accession No. 0001214659-25-002303
Filing Date
2025-02-10
Accepted
2025-02-10 12:56:05
Documents
1

Document Format Files

Seq Description Document Type Size
1 primary_doc.html SCHEDULE 13G  
1 primary_doc.xml SCHEDULE 13G 7613
  Complete submission text file 0001214659-25-002303.txt   9283
Mailing Address 600 THIRD AVENUE 2ND FLOOR NEW YORK NY 10016
Business Address 600 THIRD AVENUE 2ND FLOOR NEW YORK NY 10016 212-601-9792
Sio Capital Management, LLC (Filed by) CIK: 0001482416 (see all company filings)

EIN.: 204586565 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SCHEDULE 13G

Mailing Address 19 VESTRY STREET NEW YORK NY 10013
Business Address 19 VESTRY STREET NEW YORK NY 10013 6474072515
BRIGHT MINDS BIOSCIENCES INC. (Subject) CIK: 0001827401 (see all company filings)

EIN.: 000000000 | State of Incorp.: A1 | Fiscal Year End: 0930
Type: SCHEDULE 13G | Act: 34 | File No.: 005-94288 | Film No.: 25604789
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)